Entropy enters the Parken Challenger Championship Group A BO1 against ImmuNe as the trader-favored side, buoyed by stronger recent form in C-Tier CS2 events, including multiple close wins in prior group stages that highlight their map versatility and clutch performance on Overpass and Ancient. ImmuNe, conversely, carries momentum concerns from inconsistent qualifier results and roster stability amid Denmark's competitive tier-2 scene, with vulnerabilities exposed in pistol rounds and mid-round executions. The single-map format introduces high variance—decided by the group stage draw—while both squads feature unchanged lineups post-recent patches, emphasizing execution in the Copenhagen LAN setting and potential for underdog upsets if ImmuNe leverages home crowd support.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedEntropy vs ImmuNe
Moneyline
$9.2K Vol.
This market will resolve to "Odd" if the total combined kills by both teams in Map 1 is an odd number.
This market will resolve to "Even" if the total combined kills by both teams in Map 1 is an even number.
"Total combined kills" includes all kills recorded during the match across all rounds, including kills during regulation rounds and overtime rounds if applicable. Team kills (friendly fire) and self-inflicted deaths (e.g., falling damage, own grenade) do not count as kills for the purposes of this market.
If no kills are recorded in Map 1, or if Map 1 is canceled (not played at all), or is delayed beyond 7 days from the scheduled date, this market will resolve to 50-50.
If Map 1 is never played due to forfeit, disqualification, or walkover, this market will resolve to 50-50.
If Map 1 is not played because the series result has already been determined (e.g., a team clinches the series before Map 1 is needed), this market will resolve to 50-50.
If Map 1 is remade, resolution will be based on the remade game only.
The primary resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event's conclusion, a consensus of credible reporting may be used instead.This market will resolve to "Odd" if the total combined rounds played by both teams in Map 1 is an odd number.
This market will resolve to "Even" if the total combined rounds played by both teams in Map 1 is an even number.
"Total combined rounds" is the sum of rounds won by both teams during the match, including any overtime rounds if applicable. For example, a match ending 13–11 would have a total of 24 rounds (even), while a match ending 13–10 would have a total of 23 rounds (odd).
If Map 1 is canceled (not played at all) or is delayed beyond 7 days from the scheduled date, this market will resolve to 50-50.
If Map 1 is never played due to forfeit, disqualification, or walkover, this market will resolve to 50-50.
If Map 1 is not played because the series result has already been determined (e.g., a team clinches the series before Map 1 is needed), this market will resolve to 50-50.
If Map 1 is remade, resolution will be based on the remade game only.
The primary resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event's conclusion, a consensus of credible reporting may be used instead.This market refers to the Counter-Strike match between Entropy and ImmuNe in the Parken Challenger Championship Group A, initially scheduled for April 10 at 7:00AM ET.
This market will resolve to "Entropy" if Entropy win the match against ImmuNe.
This market will resolve to "ImmuNe" if ImmuNe win the match against Entropy.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.Entropy enters the Parken Challenger Championship Group A BO1 against ImmuNe as the trader-favored side, buoyed by stronger recent form in C-Tier CS2 events, including multiple close wins in prior group stages that highlight their map versatility and clutch performance on Overpass and Ancient. ImmuNe, conversely, carries momentum concerns from inconsistent qualifier results and roster stability amid Denmark's competitive tier-2 scene, with vulnerabilities exposed in pistol rounds and mid-round executions. The single-map format introduces high variance—decided by the group stage draw—while both squads feature unchanged lineups post-recent patches, emphasizing execution in the Copenhagen LAN setting and potential for underdog upsets if ImmuNe leverages home crowd support.
This market refers to the Counter-Strike match between Entropy and ImmuNe in the Parken Challenger Championship Group A, initially scheduled for April 10 at 7:00AM ET.
This market will resolve to "Entropy" if Entropy win the match against ImmuNe.
This market will resolve to "ImmuNe" if ImmuNe win the match against Entropy.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.This market refers to the Counter-Strike match between Entropy and ImmuNe in the Parken Challenger Championship Group A, initially scheduled for April 10 at 7:00AM ET.
This market will resolve to "Entropy" if Entropy win the match against ImmuNe.
This market will resolve to "ImmuNe" if ImmuNe win the match against Entropy.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
This market will resolve to "Entropy" if Entropy win the match against ImmuNe.
This market will resolve to "ImmuNe" if ImmuNe win the match against Entropy.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
Market Opened: Apr 9, 2026, 11:30 AM ET
Volume
$9,281End Date
Apr 10, 2026Market Opened
Apr 9, 2026, 11:30 AM ETResolution Source
https://hltv.orgResolver
0x65070BE91...Odd/Even Total Kills
$0 Vol.
Odd/Even Total Rounds
$80 Vol.
This market will resolve to "Odd" if the total combined kills by both teams in Map 1 is an odd number.
This market will resolve to "Even" if the total combined kills by both teams in Map 1 is an even number.
"Total combined kills" includes all kills recorded during the match across all rounds, including kills during regulation rounds and overtime rounds if applicable. Team kills (friendly fire) and self-inflicted deaths (e.g., falling damage, own grenade) do not count as kills for the purposes of this market.
If no kills are recorded in Map 1, or if Map 1 is canceled (not played at all), or is delayed beyond 7 days from the scheduled date, this market will resolve to 50-50.
If Map 1 is never played due to forfeit, disqualification, or walkover, this market will resolve to 50-50.
If Map 1 is not played because the series result has already been determined (e.g., a team clinches the series before Map 1 is needed), this market will resolve to 50-50.
If Map 1 is remade, resolution will be based on the remade game only.
The primary resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event's conclusion, a consensus of credible reporting may be used instead.This market will resolve to "Odd" if the total combined rounds played by both teams in Map 1 is an odd number.
This market will resolve to "Even" if the total combined rounds played by both teams in Map 1 is an even number.
"Total combined rounds" is the sum of rounds won by both teams during the match, including any overtime rounds if applicable. For example, a match ending 13–11 would have a total of 24 rounds (even), while a match ending 13–10 would have a total of 23 rounds (odd).
If Map 1 is canceled (not played at all) or is delayed beyond 7 days from the scheduled date, this market will resolve to 50-50.
If Map 1 is never played due to forfeit, disqualification, or walkover, this market will resolve to 50-50.
If Map 1 is not played because the series result has already been determined (e.g., a team clinches the series before Map 1 is needed), this market will resolve to 50-50.
If Map 1 is remade, resolution will be based on the remade game only.
The primary resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event's conclusion, a consensus of credible reporting may be used instead.This market refers to the Counter-Strike match between Entropy and ImmuNe in the Parken Challenger Championship Group A, initially scheduled for April 10 at 7:00AM ET.
This market will resolve to "Entropy" if Entropy win the match against ImmuNe.
This market will resolve to "ImmuNe" if ImmuNe win the match against Entropy.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.Entropy enters the Parken Challenger Championship Group A BO1 against ImmuNe as the trader-favored side, buoyed by stronger recent form in C-Tier CS2 events, including multiple close wins in prior group stages that highlight their map versatility and clutch performance on Overpass and Ancient. ImmuNe, conversely, carries momentum concerns from inconsistent qualifier results and roster stability amid Denmark's competitive tier-2 scene, with vulnerabilities exposed in pistol rounds and mid-round executions. The single-map format introduces high variance—decided by the group stage draw—while both squads feature unchanged lineups post-recent patches, emphasizing execution in the Copenhagen LAN setting and potential for underdog upsets if ImmuNe leverages home crowd support.
This market refers to the Counter-Strike match between Entropy and ImmuNe in the Parken Challenger Championship Group A, initially scheduled for April 10 at 7:00AM ET.
This market will resolve to "Entropy" if Entropy win the match against ImmuNe.
This market will resolve to "ImmuNe" if ImmuNe win the match against Entropy.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.This market refers to the Counter-Strike match between Entropy and ImmuNe in the Parken Challenger Championship Group A, initially scheduled for April 10 at 7:00AM ET.
This market will resolve to "Entropy" if Entropy win the match against ImmuNe.
This market will resolve to "ImmuNe" if ImmuNe win the match against Entropy.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
This market will resolve to "Entropy" if Entropy win the match against ImmuNe.
This market will resolve to "ImmuNe" if ImmuNe win the match against Entropy.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
Market Opened: Apr 9, 2026, 11:30 AM ET
Volume
$9,281End Date
Apr 10, 2026Market Opened
Apr 9, 2026, 11:30 AM ETResolution Source
https://hltv.orgResolver
0x65070BE91...Entropy enters the Parken Challenger Championship Group A BO1 against ImmuNe as the trader-favored side, buoyed by stronger recent form in C-Tier CS2 events, including multiple close wins in prior group stages that highlight their map versatility and clutch performance on Overpass and Ancient. ImmuNe, conversely, carries momentum concerns from inconsistent qualifier results and roster stability amid Denmark's competitive tier-2 scene, with vulnerabilities exposed in pistol rounds and mid-round executions. The single-map format introduces high variance—decided by the group stage draw—while both squads feature unchanged lineups post-recent patches, emphasizing execution in the Copenhagen LAN setting and potential for underdog upsets if ImmuNe leverages home crowd support.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedBeware of external links.
Beware of external links.
Frequently Asked Questions
The “ImmuNe vs. Entropy” market on Polymarket lets you trade on the outcome of the Counter-Strike 2 match between ImmuNe and Entropy in the Parken Challenger Championship, scheduled for April 10, 2026 at 7:10 AM ET. This is a Best of 1 series. The primary market is the series moneyline — which team will win the match — where ImmuNe is currently priced at 0¢ (0% implied probability) and Entropy at 100¢ (100%). Beyond the series moneyline, esports markets on Polymarket may feature individual map winners, map handicaps, and total maps, giving you multiple ways to trade on this match. Prices reflect real-time crowd-sourced probabilities. Shares in the correct outcome pay out $1 each when the market resolves after the match ends.
As of now, the “ImmuNe vs. Entropy” market has generated $9.3K in total trading volume across all market types (series moneyline, individual map winners, map handicaps, and total maps). This volume reflects active engagement from the Polymarket trading community, and a deeper pool of traders generally means more informative, reliable odds. You can track live price movements and trade on any market directly on this page.
To trade on “ImmuNe vs. Entropy,” start by choosing the market type you want to trade: Series Moneyline (which team wins the match), Individual Map Winners (who wins a specific map in the series), Map Handicap (map-win margin), or Total Maps (over/under on the number of maps played). Each market shows the current price for each side — for example, the moneyline shows IMMUNE at 0¢ and ENT2 at 100¢. Select the side you want to trade, choose Buy to take a position or Sell to close an existing one, enter your amount, and click Trade. If your chosen side is correct when the match ends and the market resolves, your shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before the match ends to lock in a profit or cut a loss.
The current series moneyline odds for “ImmuNe vs. Entropy” show ImmuNe at 0¢ (0% implied probability) and Entropy at 100¢ (100%). All odds update in real-time as traders buy and sell shares, reflecting the latest collective view of how this match will play out. Check back frequently or bookmark this page to follow how the odds shift as match time approaches.
Yes. You don't need to trade to stay informed. This page serves as a live odds tracker for the ImmuNe vs. Entropy match. The series moneyline, individual map winner, map handicap, and total maps odds all update in real-time as new trades come in. You can use the chart to track line movement as match time approaches — shifts in the odds often signal new information like roster changes, recent form, or sharp action from big traders. Check out Head to Head, Form Guide, and Map Winrate on certain matchups for deeper data and context. Bookmark this page, check the comments section to see what other traders are saying, and use the time-range filters on the chart to review how the odds have shifted. It's a free, real-time window into what the market expects.
Polymarket odds are set by real traders putting real money behind their beliefs, which tends to produce well-calibrated probabilities. With $9.3K traded on “ImmuNe vs. Entropy,” these prices aggregate the collective knowledge and conviction of active participants — similar to how traditional sportsbooks reflect sharp and public money, but in an open, transparent market anyone can participate in. Prediction markets have a strong track record of accuracy, especially as events approach their resolution. For the latest stats, visit the accuracy page on Polymarket.
To place your first trade on “ImmuNe vs. Entropy,” sign up for a free Polymarket account and fund it using crypto, a credit or debit card, or a bank transfer. Once your account is funded, return to this page and choose a market type — Series Moneyline, Individual Map Winners, Map Handicap, or Total Maps — select the side you want to trade (e.g., IMMUNE or ENT2 on the moneyline), enter your amount, and click Trade. If you're new to prediction markets, click the “How it works” link at the top of any Polymarket page for a step-by-step walkthrough.
On Polymarket, the price of each side in a market represents the market's implied probability. A price of 0¢ for IMMUNE on the series moneyline means traders collectively believe there is roughly a 0% chance that ImmuNe will win this match. If you buy IMMUNE shares at 0¢ and they win, you receive $1 per share — a profit of 100¢ per share. If they lose, those shares are worth $0. The same logic applies to individual map winners, map handicaps, and total maps: a lower price means a higher potential payout but a lower implied probability of being correct.
The “ImmuNe vs. Entropy” match is scheduled for April 10, 2026 at 7:10 AM ET in the Parken Challenger Championship. Trading remains open and odds will continue to shift as new information emerges leading up to the match. The market resolves once the series concludes and the official results are confirmed by the resolution source. The exact resolution timing depends on how many maps are played in the Best of 1 series.
The “ImmuNe vs. Entropy” market has 5,990 comments where traders share their analysis, debate match outcomes, and discuss breaking developments like roster changes and recent form. Scroll down to the comments section to join the conversation. You can also check the Top Holders tab to see how the market's biggest traders are positioned, or view the Activity tab for a real-time feed of trades being placed.
Polymarket is the world's largest prediction market, where you can stay informed and trade on real-world events. Traders buy and sell shares on outcomes across politics, sports, crypto, finance, tech, culture, and esports — including tournaments and matches across League of Legends, CS2, Valorant, Dota 2, and more. Prices reflect real-time, crowd-sourced probabilities backed by real money, offering a transparent, market-driven alternative to traditional odds sources. Whether you're a seasoned esports trader or just getting started, Polymarket lets you put your knowledge to work.
Entropy vs ImmuNe
Moneyline
$9.2K Vol.
This market will resolve to "Odd" if the total combined kills by both teams in Map 1 is an odd number.
This market will resolve to "Even" if the total combined kills by both teams in Map 1 is an even number.
"Total combined kills" includes all kills recorded during the match across all rounds, including kills during regulation rounds and overtime rounds if applicable. Team kills (friendly fire) and self-inflicted deaths (e.g., falling damage, own grenade) do not count as kills for the purposes of this market.
If no kills are recorded in Map 1, or if Map 1 is canceled (not played at all), or is delayed beyond 7 days from the scheduled date, this market will resolve to 50-50.
If Map 1 is never played due to forfeit, disqualification, or walkover, this market will resolve to 50-50.
If Map 1 is not played because the series result has already been determined (e.g., a team clinches the series before Map 1 is needed), this market will resolve to 50-50.
If Map 1 is remade, resolution will be based on the remade game only.
The primary resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event's conclusion, a consensus of credible reporting may be used instead.This market will resolve to "Odd" if the total combined rounds played by both teams in Map 1 is an odd number.
This market will resolve to "Even" if the total combined rounds played by both teams in Map 1 is an even number.
"Total combined rounds" is the sum of rounds won by both teams during the match, including any overtime rounds if applicable. For example, a match ending 13–11 would have a total of 24 rounds (even), while a match ending 13–10 would have a total of 23 rounds (odd).
If Map 1 is canceled (not played at all) or is delayed beyond 7 days from the scheduled date, this market will resolve to 50-50.
If Map 1 is never played due to forfeit, disqualification, or walkover, this market will resolve to 50-50.
If Map 1 is not played because the series result has already been determined (e.g., a team clinches the series before Map 1 is needed), this market will resolve to 50-50.
If Map 1 is remade, resolution will be based on the remade game only.
The primary resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event's conclusion, a consensus of credible reporting may be used instead.This market refers to the Counter-Strike match between Entropy and ImmuNe in the Parken Challenger Championship Group A, initially scheduled for April 10 at 7:00AM ET.
This market will resolve to "Entropy" if Entropy win the match against ImmuNe.
This market will resolve to "ImmuNe" if ImmuNe win the match against Entropy.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.Entropy enters the Parken Challenger Championship Group A BO1 against ImmuNe as the trader-favored side, buoyed by stronger recent form in C-Tier CS2 events, including multiple close wins in prior group stages that highlight their map versatility and clutch performance on Overpass and Ancient. ImmuNe, conversely, carries momentum concerns from inconsistent qualifier results and roster stability amid Denmark's competitive tier-2 scene, with vulnerabilities exposed in pistol rounds and mid-round executions. The single-map format introduces high variance—decided by the group stage draw—while both squads feature unchanged lineups post-recent patches, emphasizing execution in the Copenhagen LAN setting and potential for underdog upsets if ImmuNe leverages home crowd support.
This market refers to the Counter-Strike match between Entropy and ImmuNe in the Parken Challenger Championship Group A, initially scheduled for April 10 at 7:00AM ET.
This market will resolve to "Entropy" if Entropy win the match against ImmuNe.
This market will resolve to "ImmuNe" if ImmuNe win the match against Entropy.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.This market refers to the Counter-Strike match between Entropy and ImmuNe in the Parken Challenger Championship Group A, initially scheduled for April 10 at 7:00AM ET.
This market will resolve to "Entropy" if Entropy win the match against ImmuNe.
This market will resolve to "ImmuNe" if ImmuNe win the match against Entropy.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
This market will resolve to "Entropy" if Entropy win the match against ImmuNe.
This market will resolve to "ImmuNe" if ImmuNe win the match against Entropy.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
Market Opened: Apr 9, 2026, 11:30 AM ET
Volume
$9,281End Date
Apr 10, 2026Market Opened
Apr 9, 2026, 11:30 AM ETResolution Source
https://hltv.orgResolver
0x65070BE91...Entropy enters the Parken Challenger Championship Group A BO1 against ImmuNe as the trader-favored side, buoyed by stronger recent form in C-Tier CS2 events, including multiple close wins in prior group stages that highlight their map versatility and clutch performance on Overpass and Ancient. ImmuNe, conversely, carries momentum concerns from inconsistent qualifier results and roster stability amid Denmark's competitive tier-2 scene, with vulnerabilities exposed in pistol rounds and mid-round executions. The single-map format introduces high variance—decided by the group stage draw—while both squads feature unchanged lineups post-recent patches, emphasizing execution in the Copenhagen LAN setting and potential for underdog upsets if ImmuNe leverages home crowd support.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedBeware of external links.
Beware of external links.
Frequently Asked Questions
The “ImmuNe vs. Entropy” market on Polymarket lets you trade on the outcome of the Counter-Strike 2 match between ImmuNe and Entropy in the Parken Challenger Championship, scheduled for April 10, 2026 at 7:10 AM ET. This is a Best of 1 series. The primary market is the series moneyline — which team will win the match — where ImmuNe is currently priced at 0¢ (0% implied probability) and Entropy at 100¢ (100%). Beyond the series moneyline, esports markets on Polymarket may feature individual map winners, map handicaps, and total maps, giving you multiple ways to trade on this match. Prices reflect real-time crowd-sourced probabilities. Shares in the correct outcome pay out $1 each when the market resolves after the match ends.
As of now, the “ImmuNe vs. Entropy” market has generated $9.3K in total trading volume across all market types (series moneyline, individual map winners, map handicaps, and total maps). This volume reflects active engagement from the Polymarket trading community, and a deeper pool of traders generally means more informative, reliable odds. You can track live price movements and trade on any market directly on this page.
To trade on “ImmuNe vs. Entropy,” start by choosing the market type you want to trade: Series Moneyline (which team wins the match), Individual Map Winners (who wins a specific map in the series), Map Handicap (map-win margin), or Total Maps (over/under on the number of maps played). Each market shows the current price for each side — for example, the moneyline shows IMMUNE at 0¢ and ENT2 at 100¢. Select the side you want to trade, choose Buy to take a position or Sell to close an existing one, enter your amount, and click Trade. If your chosen side is correct when the match ends and the market resolves, your shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before the match ends to lock in a profit or cut a loss.
The current series moneyline odds for “ImmuNe vs. Entropy” show ImmuNe at 0¢ (0% implied probability) and Entropy at 100¢ (100%). All odds update in real-time as traders buy and sell shares, reflecting the latest collective view of how this match will play out. Check back frequently or bookmark this page to follow how the odds shift as match time approaches.
Yes. You don't need to trade to stay informed. This page serves as a live odds tracker for the ImmuNe vs. Entropy match. The series moneyline, individual map winner, map handicap, and total maps odds all update in real-time as new trades come in. You can use the chart to track line movement as match time approaches — shifts in the odds often signal new information like roster changes, recent form, or sharp action from big traders. Check out Head to Head, Form Guide, and Map Winrate on certain matchups for deeper data and context. Bookmark this page, check the comments section to see what other traders are saying, and use the time-range filters on the chart to review how the odds have shifted. It's a free, real-time window into what the market expects.
Polymarket odds are set by real traders putting real money behind their beliefs, which tends to produce well-calibrated probabilities. With $9.3K traded on “ImmuNe vs. Entropy,” these prices aggregate the collective knowledge and conviction of active participants — similar to how traditional sportsbooks reflect sharp and public money, but in an open, transparent market anyone can participate in. Prediction markets have a strong track record of accuracy, especially as events approach their resolution. For the latest stats, visit the accuracy page on Polymarket.
To place your first trade on “ImmuNe vs. Entropy,” sign up for a free Polymarket account and fund it using crypto, a credit or debit card, or a bank transfer. Once your account is funded, return to this page and choose a market type — Series Moneyline, Individual Map Winners, Map Handicap, or Total Maps — select the side you want to trade (e.g., IMMUNE or ENT2 on the moneyline), enter your amount, and click Trade. If you're new to prediction markets, click the “How it works” link at the top of any Polymarket page for a step-by-step walkthrough.
On Polymarket, the price of each side in a market represents the market's implied probability. A price of 0¢ for IMMUNE on the series moneyline means traders collectively believe there is roughly a 0% chance that ImmuNe will win this match. If you buy IMMUNE shares at 0¢ and they win, you receive $1 per share — a profit of 100¢ per share. If they lose, those shares are worth $0. The same logic applies to individual map winners, map handicaps, and total maps: a lower price means a higher potential payout but a lower implied probability of being correct.
The “ImmuNe vs. Entropy” match is scheduled for April 10, 2026 at 7:10 AM ET in the Parken Challenger Championship. Trading remains open and odds will continue to shift as new information emerges leading up to the match. The market resolves once the series concludes and the official results are confirmed by the resolution source. The exact resolution timing depends on how many maps are played in the Best of 1 series.
The “ImmuNe vs. Entropy” market has 5,990 comments where traders share their analysis, debate match outcomes, and discuss breaking developments like roster changes and recent form. Scroll down to the comments section to join the conversation. You can also check the Top Holders tab to see how the market's biggest traders are positioned, or view the Activity tab for a real-time feed of trades being placed.
Polymarket is the world's largest prediction market, where you can stay informed and trade on real-world events. Traders buy and sell shares on outcomes across politics, sports, crypto, finance, tech, culture, and esports — including tournaments and matches across League of Legends, CS2, Valorant, Dota 2, and more. Prices reflect real-time, crowd-sourced probabilities backed by real money, offering a transparent, market-driven alternative to traditional odds sources. Whether you're a seasoned esports trader or just getting started, Polymarket lets you put your knowledge to work.
Odd/Even Total Kills
$0 Vol.
Odd/Even Total Rounds
$80 Vol.
This market will resolve to "Odd" if the total combined kills by both teams in Map 1 is an odd number.
This market will resolve to "Even" if the total combined kills by both teams in Map 1 is an even number.
"Total combined kills" includes all kills recorded during the match across all rounds, including kills during regulation rounds and overtime rounds if applicable. Team kills (friendly fire) and self-inflicted deaths (e.g., falling damage, own grenade) do not count as kills for the purposes of this market.
If no kills are recorded in Map 1, or if Map 1 is canceled (not played at all), or is delayed beyond 7 days from the scheduled date, this market will resolve to 50-50.
If Map 1 is never played due to forfeit, disqualification, or walkover, this market will resolve to 50-50.
If Map 1 is not played because the series result has already been determined (e.g., a team clinches the series before Map 1 is needed), this market will resolve to 50-50.
If Map 1 is remade, resolution will be based on the remade game only.
The primary resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event's conclusion, a consensus of credible reporting may be used instead.This market will resolve to "Odd" if the total combined rounds played by both teams in Map 1 is an odd number.
This market will resolve to "Even" if the total combined rounds played by both teams in Map 1 is an even number.
"Total combined rounds" is the sum of rounds won by both teams during the match, including any overtime rounds if applicable. For example, a match ending 13–11 would have a total of 24 rounds (even), while a match ending 13–10 would have a total of 23 rounds (odd).
If Map 1 is canceled (not played at all) or is delayed beyond 7 days from the scheduled date, this market will resolve to 50-50.
If Map 1 is never played due to forfeit, disqualification, or walkover, this market will resolve to 50-50.
If Map 1 is not played because the series result has already been determined (e.g., a team clinches the series before Map 1 is needed), this market will resolve to 50-50.
If Map 1 is remade, resolution will be based on the remade game only.
The primary resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event's conclusion, a consensus of credible reporting may be used instead.This market refers to the Counter-Strike match between Entropy and ImmuNe in the Parken Challenger Championship Group A, initially scheduled for April 10 at 7:00AM ET.
This market will resolve to "Entropy" if Entropy win the match against ImmuNe.
This market will resolve to "ImmuNe" if ImmuNe win the match against Entropy.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.Entropy enters the Parken Challenger Championship Group A BO1 against ImmuNe as the trader-favored side, buoyed by stronger recent form in C-Tier CS2 events, including multiple close wins in prior group stages that highlight their map versatility and clutch performance on Overpass and Ancient. ImmuNe, conversely, carries momentum concerns from inconsistent qualifier results and roster stability amid Denmark's competitive tier-2 scene, with vulnerabilities exposed in pistol rounds and mid-round executions. The single-map format introduces high variance—decided by the group stage draw—while both squads feature unchanged lineups post-recent patches, emphasizing execution in the Copenhagen LAN setting and potential for underdog upsets if ImmuNe leverages home crowd support.
This market refers to the Counter-Strike match between Entropy and ImmuNe in the Parken Challenger Championship Group A, initially scheduled for April 10 at 7:00AM ET.
This market will resolve to "Entropy" if Entropy win the match against ImmuNe.
This market will resolve to "ImmuNe" if ImmuNe win the match against Entropy.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.This market refers to the Counter-Strike match between Entropy and ImmuNe in the Parken Challenger Championship Group A, initially scheduled for April 10 at 7:00AM ET.
This market will resolve to "Entropy" if Entropy win the match against ImmuNe.
This market will resolve to "ImmuNe" if ImmuNe win the match against Entropy.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
This market will resolve to "Entropy" if Entropy win the match against ImmuNe.
This market will resolve to "ImmuNe" if ImmuNe win the match against Entropy.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
Market Opened: Apr 9, 2026, 11:30 AM ET
Volume
$9,281End Date
Apr 10, 2026Market Opened
Apr 9, 2026, 11:30 AM ETResolution Source
https://hltv.orgResolver
0x65070BE91...Entropy enters the Parken Challenger Championship Group A BO1 against ImmuNe as the trader-favored side, buoyed by stronger recent form in C-Tier CS2 events, including multiple close wins in prior group stages that highlight their map versatility and clutch performance on Overpass and Ancient. ImmuNe, conversely, carries momentum concerns from inconsistent qualifier results and roster stability amid Denmark's competitive tier-2 scene, with vulnerabilities exposed in pistol rounds and mid-round executions. The single-map format introduces high variance—decided by the group stage draw—while both squads feature unchanged lineups post-recent patches, emphasizing execution in the Copenhagen LAN setting and potential for underdog upsets if ImmuNe leverages home crowd support.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedBeware of external links.
Beware of external links.
Frequently Asked Questions
The “ImmuNe vs. Entropy” market on Polymarket lets you trade on the outcome of the Counter-Strike 2 match between ImmuNe and Entropy in the Parken Challenger Championship, scheduled for April 10, 2026 at 7:10 AM ET. This is a Best of 1 series. The primary market is the series moneyline — which team will win the match — where ImmuNe is currently priced at 0¢ (0% implied probability) and Entropy at 100¢ (100%). Beyond the series moneyline, esports markets on Polymarket may feature individual map winners, map handicaps, and total maps, giving you multiple ways to trade on this match. Prices reflect real-time crowd-sourced probabilities. Shares in the correct outcome pay out $1 each when the market resolves after the match ends.
As of now, the “ImmuNe vs. Entropy” market has generated $9.3K in total trading volume across all market types (series moneyline, individual map winners, map handicaps, and total maps). This volume reflects active engagement from the Polymarket trading community, and a deeper pool of traders generally means more informative, reliable odds. You can track live price movements and trade on any market directly on this page.
To trade on “ImmuNe vs. Entropy,” start by choosing the market type you want to trade: Series Moneyline (which team wins the match), Individual Map Winners (who wins a specific map in the series), Map Handicap (map-win margin), or Total Maps (over/under on the number of maps played). Each market shows the current price for each side — for example, the moneyline shows IMMUNE at 0¢ and ENT2 at 100¢. Select the side you want to trade, choose Buy to take a position or Sell to close an existing one, enter your amount, and click Trade. If your chosen side is correct when the match ends and the market resolves, your shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before the match ends to lock in a profit or cut a loss.
The current series moneyline odds for “ImmuNe vs. Entropy” show ImmuNe at 0¢ (0% implied probability) and Entropy at 100¢ (100%). All odds update in real-time as traders buy and sell shares, reflecting the latest collective view of how this match will play out. Check back frequently or bookmark this page to follow how the odds shift as match time approaches.
Yes. You don't need to trade to stay informed. This page serves as a live odds tracker for the ImmuNe vs. Entropy match. The series moneyline, individual map winner, map handicap, and total maps odds all update in real-time as new trades come in. You can use the chart to track line movement as match time approaches — shifts in the odds often signal new information like roster changes, recent form, or sharp action from big traders. Check out Head to Head, Form Guide, and Map Winrate on certain matchups for deeper data and context. Bookmark this page, check the comments section to see what other traders are saying, and use the time-range filters on the chart to review how the odds have shifted. It's a free, real-time window into what the market expects.
Polymarket odds are set by real traders putting real money behind their beliefs, which tends to produce well-calibrated probabilities. With $9.3K traded on “ImmuNe vs. Entropy,” these prices aggregate the collective knowledge and conviction of active participants — similar to how traditional sportsbooks reflect sharp and public money, but in an open, transparent market anyone can participate in. Prediction markets have a strong track record of accuracy, especially as events approach their resolution. For the latest stats, visit the accuracy page on Polymarket.
To place your first trade on “ImmuNe vs. Entropy,” sign up for a free Polymarket account and fund it using crypto, a credit or debit card, or a bank transfer. Once your account is funded, return to this page and choose a market type — Series Moneyline, Individual Map Winners, Map Handicap, or Total Maps — select the side you want to trade (e.g., IMMUNE or ENT2 on the moneyline), enter your amount, and click Trade. If you're new to prediction markets, click the “How it works” link at the top of any Polymarket page for a step-by-step walkthrough.
On Polymarket, the price of each side in a market represents the market's implied probability. A price of 0¢ for IMMUNE on the series moneyline means traders collectively believe there is roughly a 0% chance that ImmuNe will win this match. If you buy IMMUNE shares at 0¢ and they win, you receive $1 per share — a profit of 100¢ per share. If they lose, those shares are worth $0. The same logic applies to individual map winners, map handicaps, and total maps: a lower price means a higher potential payout but a lower implied probability of being correct.
The “ImmuNe vs. Entropy” match is scheduled for April 10, 2026 at 7:10 AM ET in the Parken Challenger Championship. Trading remains open and odds will continue to shift as new information emerges leading up to the match. The market resolves once the series concludes and the official results are confirmed by the resolution source. The exact resolution timing depends on how many maps are played in the Best of 1 series.
The “ImmuNe vs. Entropy” market has 5,990 comments where traders share their analysis, debate match outcomes, and discuss breaking developments like roster changes and recent form. Scroll down to the comments section to join the conversation. You can also check the Top Holders tab to see how the market's biggest traders are positioned, or view the Activity tab for a real-time feed of trades being placed.
Polymarket is the world's largest prediction market, where you can stay informed and trade on real-world events. Traders buy and sell shares on outcomes across politics, sports, crypto, finance, tech, culture, and esports — including tournaments and matches across League of Legends, CS2, Valorant, Dota 2, and more. Prices reflect real-time, crowd-sourced probabilities backed by real money, offering a transparent, market-driven alternative to traditional odds sources. Whether you're a seasoned esports trader or just getting started, Polymarket lets you put your knowledge to work.
Beware of external links.
Beware of external links.
Frequently Asked Questions